| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/07/2002 | WO2002019602A2 Statistical modeling to analyze large data arrays |
| 03/07/2002 | WO2002019594A2 Scanning fluorescence lifetime microscope: directed evolution |
| 03/07/2002 | WO2002019407A2 A method for spatial distribution of chemical groups on a semiconductor surface |
| 03/07/2002 | WO2002018956A2 Apparatus and methods for analysing samples |
| 03/07/2002 | WO2002018954A2 Inhibition of cmv infection and dissemination |
| 03/07/2002 | WO2002018953A1 Highly reproducible agglutination immunoassay method and reagents |
| 03/07/2002 | WO2002018952A2 Biosensor assay device and method |
| 03/07/2002 | WO2002018951A2 Methods employing fluorescence quenching by metal surfaces |
| 03/07/2002 | WO2002018950A1 Detection of anti-glycolipid antibodies by latex agglutination assay |
| 03/07/2002 | WO2002018949A2 Capillary array and related methods |
| 03/07/2002 | WO2002018947A1 Method of diagnosing blood tumor and diagnostics |
| 03/07/2002 | WO2002018946A2 Immobilised phosphatidic acid probe |
| 03/07/2002 | WO2002018944A2 Means for diagnosing tumours |
| 03/07/2002 | WO2002018943A1 Methods for predicting impaired performance in equines |
| 03/07/2002 | WO2002018942A1 Kit and method for determining the redox state in urine |
| 03/07/2002 | WO2002018941A2 Screen for glutamate reuptake inhibitors, stimulators, and modulators |
| 03/07/2002 | WO2002018940A2 Device for measuring analyte concentration in a fluid |
| 03/07/2002 | WO2002018938A1 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
| 03/07/2002 | WO2002018937A1 Device and method for the measurement of forces from living materials |
| 03/07/2002 | WO2002018934A1 Method for determining the thermal material properties of metal shaped parts |
| 03/07/2002 | WO2002018932A1 Method and device for monitoring the material composition of liquid separatable media |
| 03/07/2002 | WO2002018927A1 Structure inspection device |
| 03/07/2002 | WO2002018917A1 A monitoring system |
| 03/07/2002 | WO2002018915A1 Process and apparatus for measuring the concentration of oil in water |
| 03/07/2002 | WO2002018823A1 Reaction card and use of same |
| 03/07/2002 | WO2002018661A2 Methods for identifying novel therapeutic agents |
| 03/07/2002 | WO2002018660A2 Detection of varicella-zoster virus |
| 03/07/2002 | WO2002018659A2 Method for determining alleles |
| 03/07/2002 | WO2002018654A1 Induction of ldl receptor expression by extracellular-signal regulated kinase, erk-1/2 |
| 03/07/2002 | WO2002018650A1 Diagnostic markers for multiple epilepsy phenotypes |
| 03/07/2002 | WO2002018648A2 Analysis of binding interactions |
| 03/07/2002 | WO2002018644A2 Mass spectrometric analysis of biopolymers |
| 03/07/2002 | WO2002018643A2 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 03/07/2002 | WO2002018640A2 Gene called aladin, involved in allgrove syndrome, its expression product and their applications |
| 03/07/2002 | WO2002018637A2 Diagnosis and treatment of prostate cancer |
| 03/07/2002 | WO2002018636A2 Improvements in and relating to marking using dna |
| 03/07/2002 | WO2002018635A2 Use of nonviable particles comprising an internal control (ic) nucleic acid |
| 03/07/2002 | WO2002018634A2 Arrays of immobilised biomolecules, production and use thereof |
| 03/07/2002 | WO2002018633A2 Determination of the ability of patients to respond to tumour treatment |
| 03/07/2002 | WO2002018632A2 Method for determining the degree of methylation of defined cytosines in genomic dna in the sequence context 5'-cpg-3' |
| 03/07/2002 | WO2002018631A2 Diagnosis of illnesses or predisposition to certain illnesses |
| 03/07/2002 | WO2002018628A1 Assay for soluble fibrin |
| 03/07/2002 | WO2002018627A1 Method of examining diseases with inborn errors of metabolism and examination apparatus therefor |
| 03/07/2002 | WO2002018626A1 Modulators of the interaction between arp2/3 and cortactin or hs-1 |
| 03/07/2002 | WO2002018625A2 Compositions and methods for detecting target microorganisms in a sample |
| 03/07/2002 | WO2002018624A2 Assay method for evaluating cell responses to infection |
| 03/07/2002 | WO2002018623A2 Methods and reagents for protease inhibition |
| 03/07/2002 | WO2002018621A2 Glut10: a novel glucose transporter in the type 2 diabetes linked region of chromosome 20q12-13.1 |
| 03/07/2002 | WO2002018620A2 Neutrokine-alpha and neutrokine-alpha splice variant |
| 03/07/2002 | WO2002018608A2 Methods for enhancing the efficacy of cancer therapy |
| 03/07/2002 | WO2002018603A1 Isomaltulose synthase |
| 03/07/2002 | WO2002018583A2 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 03/07/2002 | WO2002018581A2 G-protein coupled receptors |
| 03/07/2002 | WO2002018575A2 Genes expressed in the cell cycle |
| 03/07/2002 | WO2002018563A1 Method for the preparation of stable and reusable biosensing granules |
| 03/07/2002 | WO2002018557A2 Human kinases |
| 03/07/2002 | WO2002018554A2 Isolated human drug-metabolizing proteins, nucleic acid moleculesand uses thereof |
| 03/07/2002 | WO2002018553A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/07/2002 | WO2002018544A2 Method and reagents for treatment of skin disorders by modulating the notch pathway |
| 03/07/2002 | WO2002018537A2 Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents |
| 03/07/2002 | WO2002018466A1 Method and device for recognition of a target molecule by means of molecularly imprinted polymers |
| 03/07/2002 | WO2002018446A2 Methods of designing and producing compounds having improved binding affinity for cd154 or other trimeric proteins |
| 03/07/2002 | WO2002018445A2 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
| 03/07/2002 | WO2002018444A2 Erbb4 antagonists |
| 03/07/2002 | WO2002018443A2 A recombinant monoclonal antibody to phosphotyrosine-containing proteins |
| 03/07/2002 | WO2002018438A1 Modified proteins, isolated novel peptides, and uses thereof |
| 03/07/2002 | WO2002018432A2 Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
| 03/07/2002 | WO2002018418A1 Antibodies specific for methylated lysines in histones |
| 03/07/2002 | WO2002018288A1 Method for obtaining a surface activation of a solid support for building biochips microarrays |
| 03/07/2002 | WO2002018108A1 Apparatus and method for extracting a sample from a strip of material |
| 03/07/2002 | WO2002017991A2 Respiratory gas sensors in flow path |
| 03/07/2002 | WO2002017969A2 Reagents and methods for the diagnosis of cmv dissemination |
| 03/07/2002 | WO2002017964A1 The synergetic effects of hgf and antibacterial treatment |
| 03/07/2002 | WO2002017963A2 Modulators of intermediate conductance calcium-activated potassium (ikca) channel activity for treating sexual dysfunction |
| 03/07/2002 | WO2002017949A2 Novel functions for dp214 |
| 03/07/2002 | WO2002017948A2 Control of crop pests and animal parasites through direct neuronal uptake |
| 03/07/2002 | WO2002017902A1 Gene conferring resistance to the antibacterial 4,5-dihydroxy-2-cyclopenten-1-one (dhcp), the protein encoded by same, and applications thereof |
| 03/07/2002 | WO2002017901A2 Oxidized forms of retinoic acid as ligands for peroxisome proliferator activated receptor gamma |
| 03/07/2002 | WO2002017900A2 Modulators of us28 (chemokines) for treating cytomegalovirus infections |
| 03/07/2002 | WO2002017858A2 Role of fosb in bone formation |
| 03/07/2002 | WO2002017711A2 Therapeutics and diagnostics based on a novel signal transduction system in platelets |
| 03/07/2002 | WO2002000005A8 Libraries displaying human antibody fragments with hybrid complementarity determining regions |
| 03/07/2002 | WO2001093743A3 Breath ketone analyzer |
| 03/07/2002 | WO2001092880A3 Method for analysis of metabolic pathways |
| 03/07/2002 | WO2001090408A3 Method for detecting and characterising activity of proteins involved in lesion and dna repair |
| 03/07/2002 | WO2001085915A3 Identifying clusters of transcription factor binding sites |
| 03/07/2002 | WO2001079269A3 Lipid binding protein 4 |
| 03/07/2002 | WO2001077675A3 Method for the prediction of preeclampsia and other diseases |
| 03/07/2002 | WO2001072663A3 High density porous materials |
| 03/07/2002 | WO2001072208A3 Method, system, and computer program product for the evaluation of glycemic control in diabetes from self-monitoring data |
| 03/07/2002 | WO2001070389A3 Cell patterning technique |
| 03/07/2002 | WO2001069229A3 Method for separating, identifying and quantifying alkaline isophosphatases by electrophoresis |
| 03/07/2002 | WO2001065462A3 Method and computer program product for designing combinatorial arrays |
| 03/07/2002 | WO2001065243A8 Method for identifying the pile of textile materials, especially for identifying pa 6 and pa 66 in carpets |
| 03/07/2002 | WO2001064872A3 Gene 2465: methods and compositions for the diagnosis and treatment of cardiovascular, hepatic and bone disease |
| 03/07/2002 | WO2001061031A3 Improved assay for protein tyrosine phosphatases |
| 03/07/2002 | WO2001060718A3 Bulk materials management apparatus and method |
| 03/07/2002 | WO2001059155A3 Interferon-alpha induced genes |
| 03/07/2002 | WO2001059130A3 Proteins producing an altered immunogenic response and methods of making and using the same |
| 03/07/2002 | WO2001059114A3 Tumor suppressor gene, p47ing3 |